Skip to main content

Mostly in Quebec

GlaxoSmithKline Inc. government contracts

GlaxoSmithKline Inc. won 66 published public contracts in Quebec between 2012 and 2026, worth $541.4 million where a value was published, from 4 public buyers. Public Works and Government Services Canada awarded it the most, with 44.

At a glance

66

Contracts won

Published award notices.

$541.4 million

Published value

From the 66 awards that published a value.

4

Public buyers

Departments, agencies, municipalities and institutions.

2012 to 2026

Years on record

First and latest published award.

Who buys from them

Top buyers

The public buyers that awarded GlaxoSmithKline Inc. the most contracts.

  1. 1Public Works and Government Services Canada44 awards · $473.6 million
  2. 2Centre d'acquisitions gouvernementales17 awards · $38 million
  3. 3Centre intégré universitaire de santé et de services sociaux de l'Ouest-de-l'Île-de-Montréal3 awards · $200,000
  4. 4Department of National Defence1 awards · $188,640

Activity

Awards by year

Published awards in the last 6 years. The current year is partial.

  • 20216 · $100.8 million
  • 20228 · $50.9 million
  • 20234 · $17.7 million
  • 20242 · $69.6 million
  • 20250
  • 20266 · $42 million

Where the number of bidders was published, the median was 2.

What they sell

Contracts by category

Largest

Largest published awards

Latest

Recently awarded

Which of GlaxoSmithKline Inc.'s contracts are coming up for renewal, and the open opportunities that fit what it sells, are in Publicus. See how it works.

Source: Publicus procurement data as of October 26, 2026. Counts are published award notices; values are disclosed amounts in Canadian dollars, and undated awards are not counted, so totals are a floor. Names are as the publishers spell them, combined where they clearly refer to the same organization.

See every contract your competitors win

A daily briefing of new opportunities in your category and province, matched to what you sell.

Use your work email, or book a 15-min call.

We use cookies to improve your experience. By continuing to use this site, you consent to our use of cookies in accordance with our Privacy Policy.